NSE
Eris Lifesciences LimitedERIS
Eris Lifesciences Limited is a pharmaceutical company that develops and markets innovative medicines for various therapeutic areas. It focuses on creating high-quality, affordable healthcare solutions.
| Key products | Pregabalin, Gabapentin, Migraine treatment |
|---|---|
| Geography | India, Europe, USA |
| Competitors | Dr. Reddy's Laboratories, Cipla Ltd. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹109.4 Cr
Institutional buyers
2 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Interim Dividend - Rs 7.21 Per Share
ex 2026-05-29
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ERISThis | — | — | — | — | — | — |
| 2 | ACMESOLAR | — | — | — | — | +3 | 6 |
| 3 | AADHARHFC | — | — | — | — | — | — |
| 4 | AARTIIND | — | — | — | — | — | — |
| 5 | ACE | — | — | — | — | — | — |
| 6 | ACUTAAS | — | — | — | — | +4 | 6 |
| 7 | ABLBL | — | — | — | — | — | — |
| 8 | AAVAS | −₹1.9 Cr | 2 | — | — | — | — |
| 9 | ABFRL | −₹142.6 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-08FilingEris Lifesciences Limited has informed the Exchange regarding 'payment made of theinterest to the holders of NUpdates
- 2026-05-29ActionInterim Dividend - Rs 7.21 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2UpdatesNeutral
payment made of theinterest to the holders of Non-convertible Debentures'.
Source PDF →
No bulk/block deals for ERIS in this window.
News & chatter on ERIS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.